Observational epidemiological studies have the dual goals of measuring disease burden and assessing the association between exposures and outcomes. This report focuses on the first of these goals and provides an overview of design considerations of commonly used approaches, specifically community surveillance studies, cross-sectional studies, and longitudinal cohort studies. Each of these designs has strengths and weaknesses, with no study design being superior in all cases. Rather, these designs are complementary to achieve a better understanding of the burden of stroke.
Background
The dual overall goals of observational studies are to measure the burden of disease and assess the association between exposures and outcomes. The focus of this report is on the former; however, as these goals are interrelated, there will be some discussion of the latter. The purpose of this paper is to provide an introduction to the approaches and methods to assess the burden of disease and outcomes with an application to stroke with other texts providing detail to enrich the points made briefly herein. 1 The two commonly used indices of the burden of a disease are prevalence and incidence, each measuring different aspects of disease burden.
Prevalence is a ''snap-shot'' measure of the proportion of the population with the disease at a specific point in time. For some diseases, such as the flu, the disease is transient with individuals developing the disease and it then resolving. In contrast, the prevalence of stroke is defined as the proportion of persons alive who have ever had a stroke. Since someone could report having had a stroke decades in the past when they could have lived at a different location, confirmation of self-reported stroke could require the retrieval of very old medical records from an array of medical centers. As such, in many studies, such as the United States (US) Behavioral Risk Factor Surveillance System (BRFSS), prevalent stroke is defined as a positive response to a question such as ''Has a doctor, nurse, or other health professional ever told you that you had a stroke?'' 2 Alternatively, ''big data'' approaches are used where electronic medical records are searched for a history of stroke. Data from the Canadian Community Health Survey suggest the agreement between self-reported stroke and stroke defined by administrative data is surprisingly low (k ¼ 0.36). 3 While the prevalence of stroke is a valid measure of the burden of stroke, it should be interpreted with caution, as a high prevalence could be the product of either a large number of people having had a stroke or a large proportion of those suffering stroke surviving the event. As such, higher quality stroke care should result in an increase in prevalence, complicating the use of the measure to compare regions/countries, assess temporal changes in the burden, or contrast differences in patient subgroups.
Incidence is defined as the number of new cases of a disease occurring during a specific period of time.
Defining an incident case of a disease requires both determining that the individual was disease-free at ''baseline'' (the beginning of the follow-up period), and classifying the individual as developing or not developing the disease over some defined follow-up period. For stroke, defining someone as stroke-free at baseline frequently relies on patient self-report, with the same challenges discussed above for prevalence. Similar to the methods for prevalence, new cases of stroke during the follow-up period can be identified by either ongoing contact with the individual, 4, 5 or through examination of diagnosis codes in administrative databases or electronic medical records. [6] [7] [8] A major advantage of the ongoing contact with individuals is the opportunity to retrieve the medical record information, allowing expert review of a suspected stroke. Big-data approaches are remarkably efficient, but they have been shown to be only modestly acceptable, with a positive predictive value in the 70% to 80% range and misclassification of non-event hospitalizaitons. 9, 10 Relative to prevalence, incidence is considered a better measure of disease burden as it is not confounded with casefatality.
Comments applicable to all observational designs
While clinical trials are ''hypothesis driven,'' observational studies tend to be ''goal oriented.'' Key to the success of any cross-sectional (or longitudinal study discussed below) is clarity and focus on the primary goal(s) of the study. Failure to be explicit and focused on the goals will invariably lead to a diffuse study that fails on many fronts. As such, the entire research team should have a clear and shared understanding of the study goals.
In a closely related issue, the size of the study, classified by either number of participants or the number of stroke events as appropriate, needs to be carefully considered. In a clinical trial, there is one primary hypothesis and as such, statistical power calculations to meet that hypothesis are relatively straightforward. However, with potentially diffuse goals of an observational study being addressed by many analyses addressing a spectrum of hypotheses, power calculations to determine sample size are sometimes less clear. Under this situation, the planning requires the consideration of several analyses associated with different aspects of the study goals, and developing power calculations for each. This process then results in different sample size estimates to achieve different components of the study, and the determination of the sample size for the cohort is frequently a compromise decision reflecting the importance of the different analyses to meet the overall study goals.
The day of the single investigator who addresses all components of a study has long passed and we have entered the era of ''team science.'' Key to success is to assemble a team with expertise in the many domains needed to mount and complete the study, frequently including (as necessary): content experts (e.g., vascular neurologists, laboratory experts, statisticians, epidemiologists, survey design experts, data managers) and others as needed.
Regardless of the study design, the importance of efficient data management systems that lower the burden of work to study staff, while ensuring the quality of data, cannot be overstated. Key to this is the involvement of professional data managers (as noted above), and provision of resources to develop systems that address issues from data entry to analysis
Opportunities and challenges of different study designs to assess disease burden
The incidence or prevalence of stroke can be estimated using an array of study designs, each with opportunities and challenges. None of these study designs is uniformly superior, and as such, one of the most important early decisions is the study design approach to be taken.
The community surveillance study
With the primary goal of estimating the incidence of stroke, the community surveillance approach has many advantages. This approach is implemented by first clearly defining a geographic region of interest, and then establishing an approach to identify all new cases of stroke in that region. These cases must then be reviewed to select only those cases in individuals residing in the defined region (i.e. excluding individuals from other regions.) In addition, some assessment of in-and out-migration should be considered, which can usually be assessed from census records. The population of the region can be estimated from census sources, and the incidence of stroke calculated as the number of new cases divided by the population in the region over the person-years of follow-up. Examples of community surveillance studies of stroke in the US include the Northern Manhattan Study (NOMAS), 11 the Greater Cincinnati/Northern Kentucky Stroke Study (GCNKSS), 12 and the Brain Attack Surveillance in Corpus Christi Study (BASIC). 13 Alternatively, ''big data'' approaches can employ electronic review of medical records for the residents of a region (commonly an entire country using the national health systems administrative data sources) to identify new cases of stroke, and to provide estimates of incidence.
admissions to review based on discharge diagnoses. It is important to not only search for strokes at the hospitals/clinics in the region, but also at hospitals/clinics near the border of the region where individuals could receive care. The medical records associated with the suspected stroke can then be retrieved and reviewed to both adjudicate the stroke event, and collect data specific to the patient and the quality of care for the stroke event. Approaches that capture all suspected stroke events for the residents of the region should be included. For example, in order to capture non-hospitalized stroke events, the GCNKSS augmented the surveillance for stroke in hospitals with a review of a 10% random sample of stroke discharges from primary care physician offices. 12 With incidence rates calculated from the number of stroke events during a specified time period divided by the population of the region, a key is also to obtain reliable estimates of the population of the region. Fortunately, these are generally available from government census effort.
Community surveillance studies commonly define the geographic region to include a sizable population, and as such, a substantial number of strokes will occur during the observation period. The major strength of the community surveillance design is that this large population and large number of stroke events can provide estimates of stroke incidence that are generally more precise than those calculated from alternative approaches, making this the most powerful approach for the first general goal of observational studies, i.e. estimating incidence. In addition, as the demographic profile of the stroke patients can be abstracted from medical records, and similar information is generally available from the census sources, this approach can be used to estimate age-race-sex specific incidence rates that could be unstable using other study designs. In addition, the surveillance can be repeated across time periods, providing reliable estimates of temporal changes in the burden of stroke. Finally, the approach is population-based and includes all residents of the regions, not requiring sampling and recruitment of individuals, and thereby avoiding issues of the representativeness of those included.
However, the approach also has shortcomings. While demographics and some additional information are available from census sources, information on many risk factors (such as hypertension, diabetes, atrial fibrillation, etc.), health behavior (such as smoking, physical activity, sleep, etc.), and psychosocial factors (such as stress, depression, etc.) are not available. As such, this approach is generally not appropriate for the second goal of observational studies: assessing the association between exposures (i.e. risk factors, health behaviors and psychosocial factors) and stroke risk. Abstracting information on these exposures from medical records is not only problematic since the information is not recorded in a systematic manner, but the information is not useful as the calculation of the relative risk requires similar information on the residents of the region who did not suffer a stroke. An additional shortcoming is that the selection of a specific region raises issues of whether the findings are generalizable to other regions. For example, are racial differences and temporal trends in stroke incidence in Northern Manhattan, Greater Cincinnati, and Corpus Christi reflective of stroke risk for the US? Finally, the study has a limited ability to assess outcomes following stroke, largely limited to status of the study participant at the time of discharge.
Suggested steps to mount a community-surveillance study are provided in Table 1 . Briefly, the first step is to define the geographic region of interest. The region should be clearly demarcated, with a size that is sufficiently large for a substantial number of stroke events to occur, but not too large to be unwieldy in the number of health care facilities involved, or to have too many stroke events to efficiently process. The health care facilities where persons who have had a suspected stroke receive care need to be identified, with attention not only to those directly in the region but also to those in bordering regions. Importantly, these facilities should be contacted to ensure that access to records and information will be provided. Next, the timing for the stroke surveillance needs to be defined with attention to ensure that population estimates for the region during the surveillance period are available. Next, the protocol for the identification of stroke cases needs to be developed (commonly, diagnosis codes.) As part of this effort, it is optimal to retrieve medical records and adjudicate them to confirm stroke events. If medical records will be reviewed, then a broader collection of diagnosis codes can be included to help ensure that true stroke events are not omitted, i.e. the goal should be to ''cast a broad net'' to catch all potential stroke events, with the non-stroke events excluded in the adjudication process. If there are not sufficient resources for medical records to be reviewed, then a more circumspect group of diagnosis codes should be used to maximize sensitivity and specificity. Substantial planning of the data to be collected during the medical records review needs to take place. There is a tendency to collect too much data, an error that comes at the price of additional staff time and generally lower quality data. This can be avoided by creating a list of targeted publications and reports that will be prepared at the end of the study, developing table shells for these manuscripts, and then only collecting data that are necessary and useful. Next, the time to complete regulatory requirements (review by ethics committees, institutional review boards, etc.) can be International Journal of Stroke, 13 (2) substantial, and it is important to start this sufficiently early that it will not cause delays in study start-up. Staff must be recruited and trained, with a thorough review of protocol and other materials developed above. It is also wise to field-test procedures with staff prior to the actual beginning of the study. For example, at least a month before the beginning of the real study, conduct surveillance for strokes for a week, retrieve medical records, perform the adjudication, and collect all pertinent data. This process can then be reviewed, with changes made to the approach, protocol, and instruments as needed.
Cross-sectional studies
The cross-sectional study is a ''snap shot'' study where both exposures and outcomes are assessed in a single evaluation. The primary advantage of this design over the community surveillance study is the ability to assess the association between exposure and outcomes (albeit in a cross-sectional manner). However, as a snap shot study, these exposures and outcomes are evaluated simultaneously, making the determination of the direction of causation between the exposure and outcome problematic, i.e. it is not completely clear if the exposure ''caused'' the outcome, or vice versa. For example, in a cross-sectional analysis showing an association between increased inflammation (e.g. higher CRP) and a greater degree of atherosclerosis, it is not clear if the a higher inflammation led to the greater atherosclerosis, or the presence of greater atherosclerosis contributed to higher inflammatory state. In addition, a cross-sectional study is generally limited to using the prevalence of disease as an index of disease burden.
Examples of cross-sectional studies include the National Health and Nutrition Examination Survey (NHANES) 18 and the BRFSS, 2 both conducted by the US Centers for Disease Control and Prevention (CDC). NHANES is conducted using a multi-stage sample of individuals with in-person assessment of risk factors and outcomes, while BRFSS is an extensive telephone interview. Both studies are repeated on an on-going basis, providing a description of temporal changes in the prevalence of conditions including stroke and temporal changes in associations between selected exposures and outcomes.
Cross-sectional studies are conducted to provide inference on a ''target'' population, and as such, the selection of the target population is the first decision in the conduct of these studies. For example, the target population for both NHANES and BRFSS is the general US population, where a sample of the population is selected and evaluated, with the goal that the sample represents or reflects the target population. Key to the sampling is the identification of the ''sampling frame,'' or a systematic way to identify all potential participants. There are several approaches to develop a sampling frame. Historically, studies used telephone random digit dialing, an approach that can contact all potential participants who have a telephone. However, with a growing number of individuals screening telephone calls prior to answering, having only cell phones, or quickly refusing to discuss the study, this approach has fallen somewhat out of favor. There has been a growing dependence on approaches where awareness of the study is introduced by sending study materials to the participant prior to the initial contact. For example, BRFSS samples numbers from commercially available lists of names with addresses and Table 1 . Suggested steps in the design of a community surveillance study
1.
Define the surveillance region.
2.
Identify health facilities where residents of the region will receive care. Contact each facility to ensure access to discharge information.
3.
Define the time period for surveillance. Ensure a source of population estimates are available for the period of stroke surveillance.
4.
Develop protocols for the identification of stroke cases. This would include, for example, which discharge diagnoses will be reviewed, deciding if medical records will be reviewed to confirm stroke events, etc.
5.
If chart review is conducted, develop instruments and forms for the abstraction of data. This could include not only the results of the stroke adjudication, but also details of the stroke event (such as stroke subtype, severity of the stroke, etc.), characteristics of the stroke patient (history of hypertension, diabetes, etc.), a description of the stroke care (use of imaging, treatment, etc.) and outcome (discharge location including death, and level of functioning).
6.
Carefully develop and test data management tools.
7.
Complete any regulatory requirements required in your institution.
8.
Recruit and train study staff.
9.
Field test procedures and staff, review results, make changes as needed.
10.
Start study, with regular review of processes.
telephone numbers, 19 while NHANES develops a listing of homes in a selected neighborhood and selects homes from that inventory listing; 20 both approaches allow for materials to be mailed to the home prior to call, with the goal of increasing participation rates.
Cross-sectional studies are an efficient approach to meet both goals of observational studies, i.e. measuring the burden of diseases, and assessing the association between exposures and outcomes. The representativeness of this sample, or how well the sample reflects the target population, is a concern in cross-sectional studies. A key determination of the representativeness of the sample is the participation rate of those selected. However, a recent report suggests that the representativeness of the sample has a much larger impact on the ability to meet the first goal of measuring the disease prevalence than the second goal of assessing associations between exposures and outcomes. 21 Specifically, the calculation of the prevalence of disease from a cross-sectional study is the proportion of the population with the condition (sometimes adjusted to reflect the sampling design), stroke in our case. However, suppose that individuals who have had a stroke feel it is important to share information in order to potentially prevent others from having a stroke, and as such are more likely to participate in the study. This would result in an overestimation of the prevalence of stroke. Conversely, suppose that the cross-sectional study required an in-person visit to a clinic, and the disabilities associated with a stroke made this burdensome, resulting in a lower participation of those with stroke. This would result in an underestimation of the prevalence of stroke. In contrast for assessing associations, for participation rates to have an impact that relationship between the exposure and outcome would have to differ between those participating and not participating. This two-stage requirement underlies the conclusion of the commentary, that ''the good news is that most empiric work suggests that declines in participation rates are not likely to have substantial influence on exposure-disease associations''. 21 However, with the goal of estimating disease burden, participation rates remain of substantial importance, implying that the sampling approach and the recruitment of representative sample is critical to avoid comprising this aim. First, it is critical that the sampling approach reflects the goals of the study. For example, suppose a goal of the study was to assess if the relationship between risk factors and stroke differed between blacks and whites. Then in the US, randomly choosing individuals according to their distribution in the US population (called ''simple random sampling'') would result in a study population that included only 14% black participants but also include 6% Asian and 1% Native American). 22 Statistically, the ability to detect black-white differences would be optimized with a sample of 50% white and 50% black, and no other races. This can be achieved by employing a ''stratified'' sampling approach, where blacks are systematically over represented relative to their distribution in the population and Asians and Native Americans are purposefully excluded. Second, the approach for contacting the potential participant needs to be thoughtfully developed. Specifically, awareness of the study needs to be raised in the community or target population, and materials for review by the participant should be carefully developed and culturally appropriate, particularly important when recruiting across different socioeconomic or minority populations. 23 In addition, more studies, including observational studies, are involving the public and representatives of the target populations in design aspects and protocol details. 24 Community engagement can contribute to setting and meeting realistic recruitment goals as well as to the overall success of the study.
Equal attention should be focused on the planning of the evaluation of the cohort. Key in this is the careful decision of what factors to measure. Like the community surveillance design, there is a strong tendency to collect data that are not central to the goals of the study, resulting in a broad array of factors many of which will never be analyzed. Again, a cost-effective approach is to focus the effort from ''beginning to end'' and plan the papers and reports to be produced from the effort. These manuscripts and reports should reflect the goals of the entire research team. It is important to keep in mind that data are not being collected for the clinical management of the patient, but rather to meet the specific goals of the study and disseminate the specific manuscripts and reports. A successful effort in the decision of what to measure focuses on each data item and why the item is being collected. Data items can play several roles. This could be: (1) an outcome measure, e.g. prevalent stroke, (2) an exposure variable (e.g. risk factor such as hypertension, or demographic factor), (3) a confounder or effect modifier of the relationship between an exposure and outcome, or (4) a factor collected to lay the groundwork for reasonably expected ancillary studies. Each potential factor to be assessed should fall into one of these categories, else it should not be measured. The biggest enemy of observational studies is complexity, and only a firm hand during the planning phase can limit the complexity.
Once the factors to be measured are identified, the next step is the selection of the instruments and approaches for data collection. Here, the keys are: (1) don't reinvent, but rather use validated approaches and questions or instruments from other successful studies, and (2) keep it simple. There are a wealth of published, validated instruments, and references to specific International Journal of Stroke, 13 (2) wording of questions for different types of administration, e.g. self-report or proxy-reported. With input from content experts, the US National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health has developed a set of recommended ''common data elements'' for clinical research with a subset specific to stroke. 25 You will find other researchers ready and willing to share the instruments and approaches they used in their studies, so contact and seek their advice. As an example of keeping it simple, suppose you want to collect data on the physical activity level of a study participant. Asking advice of someone in exercise science might result in the recommendation to have the participant wear an accelerometer for a week or so to get an objective measure of physical activity. Another recommendation could be the International Physical Activity Questionnaire (IPAQ) as a self-administered questionnaire. 26 Alternatively, you could use the validated single question: ''How many times per week do you engage in intense physical activity, enough to work up a sweat?'' and gather a very good estimate of the underlying factor of physical activity using only a single question. 27 Importantly, minimizing participant burden will result in higher quality responses for all data items.
Once the instruments/questions have been selected, it is important to plan the participant contact. Unlike clinical trials, observational studies can include a wider range of data collection methods. As such, careful planning regarding which factors will be evaluated in what specific order is important. A focus of the effort must be to minimize participant burden. As such, general rules should be to keep in-person interview time to less than 2 h and telephone interviews to less than 45 min, on average. While this time sounds generous, a sizable proportion of the time is (appropriately) allocated to addressing questions and comments from the participant. Some data collection activities can affect the results of other evaluations, for example blood pressures should not be taken after venipuncture.
Once all is in place, there is absolutely no substitute for a field test of the protocol, methods, and instruments. Mistakes in planning will rapidly become obvious by testing the scheme in a relatively small number of participants. 28 Once in place, the full study is ready to begin. The quality of data should be monitored throughout. It is useful to produce summary data reports on a periodic basis. Again this effort will identify shortcomings early in the study while changes are still feasible.
Finally, the appropriate analysis of the resulting data also requires planning. In clinical trials, a statistical analysis plan is commonly developed for the assessment of the primary hypotheses. In a crosssectional study, there is much more latitude in the development of statistical plans. It is important not to abuse this latitude by falling into the habit or approach of data dredging, i.e. analysis and reanalysis until the ''right'' answer is provided. As such, each analysis should follow the general approach of targeting a preplanned hypothesis or aim, and the pre-specified analysis plan is generally followed, hence, minimizing the likelihood of reporting spurious findings.
Longitudinal cohort studies
Longitudinal studies normally have a ''baseline evaluation'' that is similar to the cross-sectional study, with the difference being follow-up assessment for some type of outcome, e.g. development of hypertension, stroke, or mortality. The greatest advantage of a longitudinal study is that the exposure characterization (present or absent, or severity if present, etc.) is assessed prior to the development of the incident outcome, providing substantially greater confidence in understanding the direction of causation. In addition, since the followup time provides for surveillance of the development of outcomes, longitudinal studies can employ estimates of incidence as an index of burden of the disease. For both of these reasons, the longitudinal study is considered the strongest observational study design.
However, with this strength comes the requirement of a longer and more expensive study, looking for and waiting for the outcome events. For example, for ages 55-64, the estimated annual incidence of stroke in the US is 0.5% for blacks and 0.2% for whites, and for ages 65-74, it is 0.8% and 0.5% respectively. 12 For a population that is half-black and half white, and half in each age strata, only 50 events would be observed each year in a population of 10,000 participants. With a goal of detecting a 1.5 black: white hazard ratio between those with and without a certain exposure, at least 255 stroke events are required to provide 90% power. Hence, this population of 10,000 people would require follow-up for more than five years to provide reasonable power. Additionally, if stroke is the primary outcome event and participants developing stroke are followed after the event, one can think of those individuals as comprising a new sub-cohort, and the follow-up of this new sub-cohort provides a powerful opportunity to characterize a variety of outcomes following stroke.
Examples of well conducted longitudinal studies include the Framingham Study (the ''mother'' of all longitudinal cardiovascular studies), 29 as well as the Oxford Vascular Study, 30 the Auckland Stroke Study, 31 the Rotterdam Study, 32 the Atherosclerosis Risk in Communities (ARIC; note the study also includes a community surveillance study), REasons for Geographic and Racial Differences in Stroke study (REGARDS). 34 Recently, ''virtual cohorts'' have also been defined and followed using administrative databases and electronic medical records. 6 These cohorts have the strength of having a massive sample size to detect small effects, but the limitation of the before-mentioned challenges of the use of administrative data to characterize the patient cohort and detect outcome events.
The conduct of a longitudinal study has much in common with a cross-sectional study, including defining the target population, developing a representative sample (more important for the estimation of the burden of disease as incidence than for the assessment of the association of exposures and outcomes), the potential need for oversampling specific groups to meet study goals, careful planning of factors to be assessed at baseline, planning the baseline cohort evaluation, the approach for developing instruments and evaluation techniques, data management processes, and the control of analysis plans to avoid spurious findings.
In addition to factors in common with cross-sectional studies, longitudinal studies introduce the challenge of methods for ascertainment of stroke events during follow-up and, in some cases, methods for retaining the cohort over time. There are several approaches to detect and categorize events during follow-up, and there will be differences related to the organization of health care in the particular country or region under investigation. Recommended criteria for an ''ideal'' stroke incidence study have been proposed and updated periodically. [35] [36] [37] A current refinement of these criteria, based on the experience of the Oxford Vascular Study and the Dijon Stroke Registry, is to include assessment of transient ischemic attacks (TIAs); this is because these may be minor strokes that are not hospitalized. 38 In one of the first examples of a US population-based longitudinal cohort study, the Framingham Study developed the paradigm of participants returning to a clinic at regular intervals combined with interim telephone contact, and surveillance of local hospitals within the local geographic region. The US national REGARDS study has employed telephone contact with study participant or a proxy to identify suspected strokes, supplemented with national death records, and national insurance coverage. 34 Again, other longitudinal studies have been detecting stroke events through electronic medical records and administrative databases. In longitudinal studies that enroll a population-based cohort, retention of the cohort over time involves careful planning. Key in this effort is minimizing participant burden, providing ongoing communications with the cohort, and the inclusion of surrogates or proxies to assist in finding participants or information about them when they are potentially lost-to-follow-up.
Case-control studies
For completeness, although no burden of disease can be estimated, we mention the case-control study, where data from individuals with the disease (stroke cases) are recruited along with individuals that are disease-free (persons who have not had a stroke). Commonly, the cases and controls are matched on important factors that may act as confounders in the assessment of exposure-outcome relationships. Data regarding exposures in the past are collected from both the cases and controls (hence, the study is sometimes called a ''retrospective study'').
Because participants were selected by their disease status, this design offers little insight to the burden of the disease (i.e. neither incidence nor prevalence estimates can be made). The primary strength of the design is that, because it is possible to identify a sizable number of patients with relatively rare diseases (such as hemorrhagic stroke), the approach is widely used to assess risk factors for these rare events. 39 
Conclusions
There are several alternative approaches for observational studies to assess the burden of disease, each with advantages and disadvantages. If the primary goal is to assess burden, then the community surveillance study is a powerful design. However, if the primary goal is to assess the relationships between exposures and outcomes, the cohort study is preferred (or the cross-sectional study if there is a focus on study time and cost). There is no best design, rather the information from these studies should be considered as complementary, and together, they can provide a rich description of the burden and outcome of stroke.
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